coronavirus October 12, 2021 8:38 am Merck Seeks FDA Authorization for COVID Pill Merck’s COVID-19 pill could decrease mortality and hospitalization rates by 50%, according to Boston Pain Center’s Dr. Roberto Feliz, as the company seeks FDA authorization for the oral treatment. US & World Videos 1:56 20-year-old killed, teen critically hurt in Northbridge double stabbing 1:02 Bruins fans hyped after Game 7 OT win over Maple Leafs 0:33 Paperwork filed to charge student accused of school shooting threats in Milton 1:50 Man found shot to death in Taunton shed 0:49 Bowling alley reopens 6 months after mass shootings in Lewiston, Maine
